Late Relapse Rates After Immunochemotherapy Treatment for Diffuse Large B-Cell Lymphoma
Patients who achieved event-free survival at 24 months following diagnosis were evaluated for late relapses.
Non-Hodgkin Lymphoma
Current and Prospective Therapies for Double-Hit Lymphoma
In a review, researchers discussed the value of combining immunotherapy, targeted therapy, and chemotherapy to improve treatment for double hit lymphoma.
Number of Comorbidities Linked to Risk of Thromboembolism in Leukemia, Lymphoma
A retrospective study sought to determine the risk factors for thromboembolism in patients with acute leukemia or lymphoma.
Response Patterns After Multiple Lines of Therapy in Mantle Cell Lymphoma
Early failure after treatment, old age, and treatment regimens not including stem cell transplantation were associated with poorer survival.
Nonrelapse Mortality After CAR-T Therapy Remains High
“Nonrelapse mortality needs to be defined prospectively for all ongoing CAR-T studies,” said the researchers.
Measuring Patient-Reported Outcomes in Waldenström Macroglobulinemia Patients Receiving Rituximab vs Ibrutinib-Rituximab
Researchers sought to further evaluate data on patient-reported outcomes from the iNNOVATE study.
Support for Multimodality Therapy in Some Patients With Follicular Lymphoma
Follicular lymphoma is classified into 3 histologic grades on the basis of the number of centroblasts per high-power field.
Consensus Panel on Maintenance Therapies Following Autologous Hematopoietic Cell Transplantation in Lymphoma
An expert panel reviewed current literature surrounding lymphoma treatment to identify and address any gaps in knowledge.
Two Measures Independently Predict for NHL in Patients With HIV
Both a high HIV viral load and a low CD4 level independently predict for the risk of NHL in patients who have HIV.
BMT Societies Issue Recommendations on Posttransplant Maintenance in HL/NHL
Use of maintenance therapy as a therapeutic strategy in posttransplant patients with HL and NHL is increasing in frequency
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...